Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Accenture
Harvard Business School
Julphar
Daiichi Sankyo
QuintilesIMS
Farmers Insurance
Teva

Generated: April 21, 2018

DrugPatentWatch Database Preview

CORVERT Drug Profile

« Back to Dashboard

When do Corvert patents expire, and what generic alternatives are available?

Corvert is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in CORVERT is ibutilide fumarate. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.
Drug patent expirations by year for CORVERT
Pharmacology for CORVERT
Drug ClassAntiarrhythmic
Synonyms for CORVERT
( inverted exclamation markA)-N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]-methanesulfonamide hemifumarate salt
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1)
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt)
(+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate
(+/-)-N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]-methanesulfonamide hemifumarate salt
(+/-)-N-[4-[4-(Ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide hemifumarate
(E)-2-butenedioic acid; N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
(E)-but-2-enedioic acid; N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
(E)-but-2-enedioic acid; N-[4-[4-[ethyl(heptyl)amino]-1-oxidanyl-butyl]phenyl]methanesulfonamide
100632-81-3
122647-31-8
122647-32-9
122647-32-9 (Fumarate)
130350-52-6
2C20H36N2O3S.C4H4O4
647I318
647I329
A804940
AB0016835
AB01568246_01
AB2000520
AC1L1TUW
AC1NQXZ2
AC1O5NJM
AC1Q6VUF
AKOS015896070
AKOS028114449
ALOBUEHUHMBRLE-UHFFFAOYSA-N
AN-32831
API0006228
AS-15378
BDBM50131432
bis(N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide) fumarate
bis(N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide); but-2-enedioic acid
Butilide fumarate
C-21412
C07753
C20H36N2O3S
C20H36N2O3S??0.5C4H4O4
CAS-122647-32-9
CC-29459
CCG-220685
CHEBI:5856
CHEBI:5857
CHEMBL1200564
CHEMBL2355456
CHEMBL533
Corvert (TN)
D00648
D02MLW
D08060
DB00308
DR003068
DSSTox_CID_28578
DSSTox_GSID_48652
DSSTox_RID_82849
DTXSID8048652
EN300-122354
FT-0631106
FUMARIC ACID; BIS(IBUTILIDE)
FUMARIC ACID; IBUTILIDE
GTPL7200
HSDB 7926
I06-1701
I0946
Ibutilid
Ibutilida
Ibutilida [INN-Spanish]
Ibutilide
Ibutilide (fumarate)
Ibutilide (INN)
Ibutilide [BAN:INN]
Ibutilide [INN:BAN]
IBUTILIDE FUMARATE
Ibutilide fumarate (USAN)
Ibutilide Fumarate [USAN]
Ibutilide fumarate, United States Pharmacopeia (USP) Reference Standard, monograph mol wt. 885.23 ([(C20H36N2O3S)2 . C4H4O4])
Ibutilide hemifumarate
Ibutilide hemifumarate salt
Ibutilide hemifumarate salt, >=98% (HPLC)
ibutilide, (+-)-isomer
ibutilide, fumarate salt (2:1), (+-)-isomer
Ibutilidum
Ibutilidum [INN-Latin]
LP012543
LP018754
LP070303
LS-172765
LS-90123
LS-90124
MCULE-5393489002
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-, (E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-,(E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-
Methanesulfonamide, N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]-, (2E)-2-butenedioate (2:1)
MFCD01715410
MolPort-019-939-237
MolPort-019-991-026
N-(4-(4-(ethyl(heptyl)amino)-1-hydroxybutyl)phenyl)methanesulfonamide
N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide
n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
N-[4-[4-(ethyl-heptyl-amino)-1-hydroxy-butyl]phenyl]methanesulfonamide fumarate
N-[4-[4-(ethylheptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide
N-[4-[4-[ethyl(heptyl)amino]-1-hydroxy-butyl]phenyl]methanesulfonamide
N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
N-{4-[4-(Ethyl-heptyl-amino)-1-hydroxy-butyl]-phenyl}-methanesulfonamide
NCGC00181771-01
NE46026
P113
s2118
SC-94637
SCHEMBL15540420
SCHEMBL1649397
SCHEMBL3719856
SCHEMBL42073
SR-01000942241
SR-01000942241-1
Tox21_113006
U 70226E
U 82209E
U-70226E
U-82208E
U-82209E
U82208E
U82209E

US Patents and Regulatory Information for CORVERT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CORVERT ibutilide fumarate INJECTABLE;INJECTION 020491-001 Dec 28, 1995 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Federal Trade Commission
AstraZeneca
Farmers Insurance
Deloitte
US Army
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.